New Ways to Give Nivolumab: Does Dose Matter for Advanced Melanoma Patients?
Nivolumab, a drug used to treat advanced melanoma, was initially given based on a person's weight (3 mg/kg every two weeks). Then, in 2018, health providers started using a flat dose (240 mg every two weeks or 480 mg every four weeks) instead. This change was made without direct proof from clinical